Elisabeth Specht Stovgaard

1.2k total citations
14 papers, 437 citations indexed

About

Elisabeth Specht Stovgaard is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Elisabeth Specht Stovgaard has authored 14 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Cancer Research and 3 papers in Molecular Biology. Recurrent topics in Elisabeth Specht Stovgaard's work include Cancer Immunotherapy and Biomarkers (6 papers), Cancer Cells and Metastasis (6 papers) and Breast Cancer Treatment Studies (2 papers). Elisabeth Specht Stovgaard is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Cancer Cells and Metastasis (6 papers) and Breast Cancer Treatment Studies (2 papers). Elisabeth Specht Stovgaard collaborates with scholars based in Denmark, Canada and Pakistan. Elisabeth Specht Stovgaard's co-authors include Eva Balslev, Dorte Nielsen, Kasper Broedbaek, Allan Weimann, Henrik E. Poulsen, Estrid Høgdall, Anne Roslind, Trine Henriksen, Anne Dyhl-Polk and Steen Joop Bonnema and has published in prestigious journals such as Diabetes Care, Cancer Research and Free Radical Biology and Medicine.

In The Last Decade

Elisabeth Specht Stovgaard

13 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisabeth Specht Stovgaard Denmark 9 177 121 94 76 48 14 437
Sarah Piel Sweden 12 115 0.6× 234 1.9× 34 0.4× 60 0.8× 34 0.7× 29 467
Ettickan Boopathi United States 15 97 0.5× 205 1.7× 60 0.6× 22 0.3× 68 1.4× 27 463
Jinge Kong China 10 78 0.4× 192 1.6× 142 1.5× 73 1.0× 39 0.8× 13 518
Özlem Küçükhüseyin Türkiye 12 78 0.4× 163 1.3× 44 0.5× 59 0.8× 27 0.6× 48 396
İlhan Yaylım Türkiye 13 82 0.5× 173 1.4× 77 0.8× 42 0.6× 44 0.9× 59 438
Boquan Wu China 13 81 0.5× 357 3.0× 107 1.1× 64 0.8× 43 0.9× 23 548
Xiaoru Hu China 12 40 0.2× 194 1.6× 75 0.8× 57 0.8× 68 1.4× 29 480
Xiaolan Yi United States 6 75 0.4× 297 2.5× 75 0.8× 76 1.0× 24 0.5× 7 537
Chandrashekar R. Ambati United States 12 87 0.5× 375 3.1× 112 1.2× 44 0.6× 53 1.1× 14 637

Countries citing papers authored by Elisabeth Specht Stovgaard

Since Specialization
Citations

This map shows the geographic impact of Elisabeth Specht Stovgaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Specht Stovgaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Specht Stovgaard more than expected).

Fields of papers citing papers by Elisabeth Specht Stovgaard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabeth Specht Stovgaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Specht Stovgaard. The network helps show where Elisabeth Specht Stovgaard may publish in the future.

Co-authorship network of co-authors of Elisabeth Specht Stovgaard

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth Specht Stovgaard. A scholar is included among the top collaborators of Elisabeth Specht Stovgaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth Specht Stovgaard. Elisabeth Specht Stovgaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Riaz, Nazia, Bingshu E. Chen, Anita Bane, et al.. (2025). Prognostic and predictive capacity of tumor infiltrating lymphocytes in the MA.20 regional node radiotherapy trial. npj Breast Cancer. 11(1). 97–97.
2.
Riaz, Nazia, Bingshu E. Chen, Anita Bane, et al.. (2023). Abstract P4-02-16: Prognostic and Predictive Capacity of Tumor Infiltrating Lymphocytes in the MA.20 regional radiotherapy trial. Cancer Research. 83(5_Supplement). P4–2. 3 indexed citations
3.
Stovgaard, Elisabeth Specht, Maj‐Britt Jensen, Karama Asleh, et al.. (2022). Neither Tumor-Infiltrating Lymphocytes nor Cytotoxic T Cells Predict Enhanced Benefit from Chemotherapy in the DBCG77B Phase III Clinical Trial. Cancers. 14(15). 3808–3808. 2 indexed citations
4.
Thagaard, Jeppe, Elisabeth Specht Stovgaard, Søren Hauberg, et al.. (2021). Automated Quantification of sTIL Density with H&E-Based Digital Image Analysis Has Prognostic Potential in Triple-Negative Breast Cancers. Cancers. 13(12). 3050–3050. 25 indexed citations
5.
Stovgaard, Elisabeth Specht, Karama Asleh, Nazia Riaz, et al.. (2021). The immune microenvironment and relation to outcome in patients with advanced breast cancer treated with docetaxel with or without gemcitabine. OncoImmunology. 10(1). 1924492–1924492. 9 indexed citations
6.
Stovgaard, Elisabeth Specht, et al.. (2020). Expression of Secretory Phospholipase A2 Group IIa in Breast Cancer and Correlation to Prognosis in a Cohort of Advanced Breast Cancer Patients. Applied immunohistochemistry & molecular morphology. 29(1). e5–e9. 8 indexed citations
7.
Stovgaard, Elisabeth Specht, Anne Roslind, Iben Kümler, et al.. (2020). PD-L1 diagnostics in the neoadjuvant setting: implications of intratumoral heterogeneity of PD-L1 expression in triple negative breast cancer for assessment in small biopsies. Breast Cancer Research and Treatment. 181(3). 553–560. 27 indexed citations
8.
Stovgaard, Elisabeth Specht, Anne Dyhl-Polk, Anne Roslind, Eva Balslev, & Dorte Nielsen. (2019). PD-L1 expression in breast cancer: expression in subtypes and prognostic significance: a systematic review. Breast Cancer Research and Treatment. 174(3). 571–584. 53 indexed citations
9.
Stovgaard, Elisabeth Specht, Dorte Nielsen, Estrid Høgdall, & Eva Balslev. (2017). Triple negative breast cancer – prognostic role of immune-related factors: a systematic review. Acta Oncologica. 57(1). 74–82. 92 indexed citations
10.
Bonnema, Steen Joop, Elisabeth Specht Stovgaard, Søren Fast, et al.. (2015). Systemic Oxidative Stress to Nucleic Acids Is Unaltered Following Radioiodine Therapy of Patients with Benign Nodular Goiter. European Thyroid Journal. 4(1). 20–25. 2 indexed citations
11.
Weimann, Allan, Kasper Broedbaek, Trine Henriksen, Elisabeth Specht Stovgaard, & Henrik E. Poulsen. (2012). Assays for urinary biomarkers of oxidatively damaged nucleic acids. Free Radical Research. 46(4). 531–540. 33 indexed citations
12.
Stovgaard, Elisabeth Specht, Tove Filtenborg Tvedskov, Anne‐Vibeke Lænkholm, & Eva Balslev. (2012). Cytokeratin on Frozen Sections of Sentinel Node May Spare Breast Cancer Patients Secondary Axillary Surgery. Pathology Research International. 2012. 1–5. 5 indexed citations
13.
Broedbaek, Kasper, Allan Weimann, Elisabeth Specht Stovgaard, & Henrik E. Poulsen. (2011). Urinary 8-oxo-7,8-dihydro-2′-deoxyguanosine as a biomarker in type 2 diabetes. Free Radical Biology and Medicine. 51(8). 1473–1479. 83 indexed citations
14.
Broedbaek, Kasper, Volkert Siersma, Trine Henriksen, et al.. (2011). Urinary Markers of Nucleic Acid Oxidation and Long-Term Mortality of Newly Diagnosed Type 2 Diabetic Patients. Diabetes Care. 34(12). 2594–2596. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026